LongeVC's Artemy Shumskiy to Speak at Informa's Cell & Gene Therapy International Europe in Berlin

Artemy Shumskiy, LongeVC senior associate, will participate in an investor panel at Informa's Cell & Gene Therapy International Europe conference in Berlin on December 1, 2025.

The panel, "Funding the Future – Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies," will bring together investors from leading venture firms to discuss the evolving investment landscape for cell and gene therapies heading into 2026.

The discussion will cover emerging opportunities in CGT and enabling technologies, strategies for standing out in a competitive funding environment, and investor perspectives on which innovations are positioned to deliver meaningful impact. The session will include an interactive Q&A focused on practical insights for founders navigating the current funding landscape.

For more information about the event, visit the official conference page here.